Autopsy report · NCT06625359

High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma

“slow enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 years 4 months after it had already started.
• Ran for about 9 years 4 months before it stopped.
• 17 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Seoul National University Hospital

Sponsor type

University, hospital or other

Conditions

Central Nervous System Lymphoma

Interventions

Thiotepa in conditioning before transplantation

Participants

17

Sites

1

Countries

South Korea

Trials that died the same way

• EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study
  “too slow enrollment” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.